The treatment of Duchenne Muscular Dystrophy – A first clinical trial in Yvelines – SQY Therapeutics

L'essai clinique de Phase 1/2a AVANCE1 a commencé

Phase 1/2a AVANCE1 clinical trial began

News

Non classé SQY Therapeutics 13 March 2023

A first clinical trial in Yvelines for the treatment of Duchenne Muscular Dystrophy. Click here.

(0 Comments)

Your email address will not be published. Required fields are marked *

Your comment*

First and Last name*

E-mail Address*

Website

Save my name, email, and website in this browser for the next time I comment.